CD207 and cancer: In contrast, there were no differences in CD207 ratios for whole biopsies (Figure 7b) and neither between CD207 ratios for either EBER or intralesional EBV DNA in selected areas (areas of cancer cells and areas of surrounding stroma) nor between CD8 ratios for EBER and intralesional EBV DNA in surrounding stroma.